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ABSTRACT: A strategy of using crystal structure prediction
(CSP) methods to determine which, if any, isostructural
template could facilitate the ﬁrst crystallization of a predicted
polymorph by vapor deposition is extended to the fenamate
family. Mefenamic acid (MFA) and tolfenamic acid (TFA) are
used as molecules with minimal chemical diﬀerences, whereas
ﬂufenamic acid (FFA) shows greater diﬀerences in the
substituents. The three crystal energy landscapes were
calculated, and periodic electronic structure calculations
were used to conﬁrm the thermodynamic plausibility of
possible isostructural polymorphs to experimentally obtain-
able crystals of the other molecules. As predicted, a new
polymorph, TFA form VI, was found by sublimation onto isomorphous MFA form I, using a recently developed technique.
MFA and TFA form a continuous solid solution with the structure of MFA I and TFA VI at the limits, but the isomorphous
MFA/FFA solid solution does not extended to a new polymorph of FFA. The novel solid solution structure of TFA and FFA
was found, and a new isomorphous polymorph TFA VII was found by sublimation onto this new solid solution template.
Sublimation of TFA onto a metal surface at the early stage of deposition gave TFA form VIII. We rationalize the formation of
new polymorphs of only TFA.
1. INTRODUCTION
A knowledge of the solid form landscape, covering at least all
polymorphs, solvates, and hydrates, is essential for the design
of robust crystallization processes and to avoid the late
appearance of unknown competing forms.1−3 Extensive eﬀorts
in polymorph screening4,5 show that the vast majority of
molecules are polymorphic,6 and yet covering all possible
crystallization conditions is not practicable because of the
marked eﬀect that impurities or deliberate seeding with related
crystals can have on the production of novel polymorphs.7−10
Computational crystal structure prediction (CSP) is emerging
as a complementary tool to polymorph screening, to help
establish whether all polymorphs of interest have been
found,11,12 but this frequently suggests that more polymorphs
are thermodynamically feasible than are experimentally
known.13 This raises the question as to whether a targeted
crystallization experiment can be devised to speciﬁcally
crystallize the unobserved low energy structures on the
computational crystal energy landscape for the ﬁrst time.13
On the basis of the knowledge of relative energies, we have
used the possibility of isostructurality between closely related
molecules as a route to ﬁnding a template to produce the ﬁrst
sample of a CSP predicted polymorph of another molecule.
The ﬁrst successful application of this strategy was in the
carbamazepine family, with the production of the ﬁrst
catemeric polymorph of carbamazepine (CBZ V) by
sublimation of CBZ onto single crystals of isomorphous
dihydrocarbamazepine (DHC II).14 (CBZ V has recently been
crystallized in another laboratory by a related templating
experiment).15 While advances in computational methods can
provide guidance to select a substrate, experiments to explore
all possible orientations between the substrate and overlaying
lattice can be very time-consuming. To address this concern, a
new approach was developed using the polycrystalline material
Received: May 18, 2018
Revised: July 25, 2018
Published: August 2, 2018
Article
pubs.acs.org/crystalCite This: Cryst. Growth Des. 2018, 18, 5322−5331
© 2018 American Chemical Society 5322 DOI: 10.1021/acs.cgd.8b00765
Cryst. Growth Des. 2018, 18, 5322−5331
This is an open access article published under a Creative Commons Attribution (CC-BY)
License, which permits unrestricted use, distribution and reproduction in any medium,
provided the author and source are cited.
D
ow
nl
oa
de
d 
vi
a 
U
N
IV
 C
O
LL
EG
E 
LO
N
D
O
N
 o
n 
Se
pt
em
be
r 1
2,
 2
01
8 
at
 1
5:
37
:3
5 
(U
TC
). 
Se
e 
ht
tp
s:/
/p
ub
s.a
cs
.o
rg
/sh
ar
in
gg
ui
de
lin
es
 fo
r o
pt
io
ns
 o
n 
ho
w
 to
 le
gi
tim
at
el
y 
sh
ar
e 
pu
bl
ish
ed
 a
rti
cl
es
. 
as substrate. The polycrystalline substrate approach provides
access to all possible orientations of the substrate in a single-
shot experiment. This strategy was validated by producing the
ﬁrst crystals of a novel polymorph of cyheptamide (CHY III),
also using DHC II crystals as the template.16
The use of isostructural crystal structures implies that the
molecules can adopt such a similar packing that they may well
form a solid-solution under experimental conditions. Indeed
the discovery of CBZ V was preceded by the demonstration
that CBZ could form catemeric hydrogen bonds in a 50:50
solid solution17 of CBZ/DHC, which is isomorphous with
DHC II. In contrast a recent study substituting methyl for Cl
or Br found solid solutions that were not isomorphous with the
pure components.18 The diﬀerences between surface-tem-
plated growth from the vapor, formation of solid solutions, and
the use of heterogeneous isostructural crystals for seeding
solutions or melts to grow a targeted new form7 are important
for understanding how similarities between predicted and
known crystal structures can be exploited in polymorph
discovery.
In this study, we sought to develop the strategy of using CSP
to determine possible templates for ﬁnding new polymorphs in
another family of molecules. The fenamates were chosen as a
contrast to the carbamazepine family, in that the fenamate
polymorphs diﬀer in conformation and packing of aromatic
rings but have the same hydrogen bonding functionality. Since
the fenamates are a family of nonsteroidal anti-inﬂammatories,
their polymorphism, transformations, and the eﬀect of diﬀerent
polymorphs on bioavailability have been extensively stud-
ied.19,20 Many fenamates are highly polymorphic: ﬂufenamic
acid (FFA) held the record for nine characterized crystal
structures, with forms IV−IX being discovered by polymer
templating.21 Tolfenamic acid (TFA) has ﬁve polymorphs,
with III−V being generated by polymer induced heteroge-
neous nucleation.22,23 Mefenamic acid (MFA) has three
reported forms, with the metastable form II produced on
heating24 or by recrystallization under pressure25 and with
form III being found serendipitously in a cocrystallization
experiment.26 These polymorphic systems have been exten-
sively used to explore methods of polymorph discovery27 and
control, including stabilizing metastable forms.28 Work seeking
to rationalize the observed polymorphism29−31 has suggested
that the “polymorphophore”22,32 nature arises from the
packing of the substituents,33 with fenamic acid34 being
monomorphic. In this study we chose to concentrate on MFA
and TFA, as the most similar molecules, as the exchange of
CH3 for Cl involves little diﬀerence in atomic volume and is a
widely used tool in crystal engineering.35 We also studied FFA
to assess the eﬀect of a more signiﬁcant change in the
substituents, which has little eﬀect on the solution properties in
polar solvents.36
Hence, this paper uses computer prediction and exper-
imental exploration of three of the polymorphic fenamates to
study the capabilities of isostructural templating as a route to
polymorph discovery by considering the following questions:
(1) Do similar molecules have isomorphous or isostructural
crystal structures that are thermodynamically plausible,
as generated by CSP methods?
(2) Can the ambient stable polymorphs (MFA I, TFA I,
FFA III) be used as templates to generate the ﬁrst
crystals of an isostructural polymorph that has been
predicted in (1), by sublimation?
(3) In cases where (2) generates a new polymorph: how
structurally similar do the template and novel polymorph
have to be? How is this related to the ability to form a
solid solution that is isomorphous with both end points?
How does the relative stability and kinetic feasibility of
the polymorphs of a molecule limit the ability to
produce further polymorphs? Can the novel polymorphs
be produced by other routes?
2. EXPERIMENTAL DETAILS
2.1. Preparation of Solid Solutions. Samples were prepared by
mixing pure preformed solutions of the two components in a common
solvent (ethanol, diethyl ether, and acetonitrile) and allowing the
sample to crystallize by slow evaporation at room temperature. Bulk
materials were analyzed by one or both of the techniques of PXRD
and 1H NMR spectroscopy to assess the composition of the solid
solution material with respect to the input molar ratios. Carefully
selected single crystals were analyzed by SCXRD, and the appropriate
occupancies were reﬁned to establish composition (Section S7.2).
Where solid solutions were prepared from melts, this was done by
ﬁnely grinding the two components into a single homogeneous
powder, which was placed between two microscope slides. The
samples were then heated to 175 °C on a Koﬂer bench followed by
slow cooling to room temperature at 5 °C/min.
2.2. Procedures for Sublimation Experiments. An array of
template crystals were mounted on a glass slide which was then
exposed to a vapor of the material to be deposited16 produced by
placing ca. 50 mg on a Petri dish which was heated to 120 °C for 24 h.
The deposited material was examined by optical microscopy, and
individual single crystals were carefully removed and characterized by
SCXRD.
2.3. Computational Methodology. The crystal energy land-
scapes were calculated by generating one million Z′ = 1 structures
using CrystalPredictor,37 in the 59 most common space groups,
including the main conformational variable of the fenamates (ϕ,
Figure 1) as a search variable. These structures were further reﬁned
using CrystalOptimizer38 to optimize the lattice energies as the sum of
the conformational energy penalty, calculated at the PBE0/6-
31+G(d) level of theory using Gaussian09,39 and the intermolecular
lattice energy calculated within DMACRYS40 using the distributed
multipoles calculated by GDMA41 and the empirical exp-6 repulsion-
dispersion model with the FIT parametrization.42 The sensitivity of
the low energy crystal structures to the computational model was
further investigated by using a polarizable continuum model (PCM, ε
= 3) to calculate the distributed multipoles and intramolecular energy
penalty,43 and also a rigid-body free energy model.44 For selected
Figure 1. Fenamates: fenamic (FA), mefenamic (MFA), tolfenamic
(TFA), and ﬂufenamic (FFA) acids. The widely varying torsion angle
is labeled on FA as ϕ.
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structures, lattice energies were also modeled using CASTEP45 with a
PBE functional46 and both the TS47 and MBD*48 dispersion models.
The nanocrystal surface calculations were performed using
ORIENT.49 Further details and analysis are in the Supporting
Information.
3. RESULTS
3.1. Are There More Fenamate Polymorphs To Be
Targeted? The CSP generated crystal energy landscapes show
that there are many lattice energy minima that do not
correspond to known forms in this extensive search for Z′ = 1
structures. Isostructural crystals were identiﬁed by having the
15 molecule coordination sphere match (Table S9). This
shows that there are far more matches between low energy
structures of TFA and MFA than with FFA, and provides an
initial estimate of how metastable the structure would be.
However, the experiments to use an isostructural template to
produce the ﬁrst nucleation of a new form are limited in that
the templating crystal must not transform to a more stable
form during the course of the experiment. We have focused
therefore on using MFA I, TFA I, and FFA III and solid
solution crystals as templates for sublimation. Looking for
matches with template structures (Figure 2 and Table S9)
shows that there is a structure of TFA that is isomorphous to
the most stable form of MFA, and thermodynamically
competitive with the metastable polymorphs of TFA. This
suggests that TFA should be sublimed onto MFA form I
crystals as a potential route to targeted crystallization of a new
polymorph of TFA, form VI.
3.2. Targeted Production of the First Crystals of TFA
form VI. Subliming TFA onto crystalline MFA form I, using
the new methodology, does indeed produce crystals of a new
form of TFA, form VI (P1̅, Z′ = 1), Figures 3, S13 and Table
S17. The structure has a similar powder X-ray diﬀraction
(PXRD) pattern to TFA IV (P1̅, Z′ = 3), produced by polymer
induced heteronucleation,21 suggesting that the templating
isomorphous crystal surface directs the TFA molecules into the
simpler, slightly more stable lattice of form VI.
The production of TFA VI by sublimation onto MFA I is
robust, as it was also produced in a separate laboratory by a
modiﬁed puriﬁcation sublimation apparatus. TFA VI can also
be obtained by seeding ethanolic solutions of TFA with MFA I
crystals and with crystals of FFA I but not FFA III (see Section
S7.1.2).
3.3. Solid Solution Extensions of Crystal Structures of
These Fenamates. All three binary solid solutions could be
formed with a substantial proportion of both molecules. The
MFA/TFA and MFA/FFA solid solutions (Sections S7.1.3 and
Figure 2. Crystal energy landscapes (CELs) of TFA, MFA, and FFA, where each black dot represents a stable structure in the lattice energy, Elatt,
evaluated within a polarizable continuum model, generated in the CSP study. Open shapes on each of the three CELs are polymorphs known by
the end of the study, shown by circles if Z′ = 1, triangles if Z′ > 1. CSP generated structures are linked to the observed structure by a larger ellipse if
not falling within the symbol. Tie-lines are drawn to link polymorphs to isostructural matches in another CEL: solid lines span structures which are
both known polymorphs, dashed lines connect a known polymorph to a hypothetical structure, and dotted lines join structures which are not
known for either molecule (although are known polymorphs for the third). Colored lines include a room temperature stable form: red - MFA I
structural type, blue - TFA/FFA solid solution (TFA VII), and green - TFA I. The structural types used as templates and the new polymorphs are
explicitly labeled, with other known polymorphs included in legends beneath each 2D plot. Full details of the structural matches are in Table S9.
Figure 3. (Left) Plates of TFA VI (circled in red) formed by
sublimation of TFA onto MFA I and (right) the overlay of the major
component of TFA VI (red) with templating structure MFA I (blue;
XYANAC) RMSD15 = 0.214 Å.
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S7.1.6) were isomorphous with MFA I. The solid solution of
TFA/FFA (Section S7.1.8) is closely related, having very
similar layers of hydrogen bonded dimers, but these are related
by a screw rather than a translation, giving a P21/c structure in
contrast to the P1̅ structures of MFA/FFA and MFA/TFA.
However, the range of composition and methods of formation
of these solid solutions diﬀer.
The solid solution of MFA and TFA results from very good
molecular matching: not only are both end points now known
(MFA I and TFA VI), but careful examination of the molecular
ratios in the solid solution, by both single crystal diﬀraction
and NMR of a CDCl3 solution prepared from the recovered
crystals, show approximately the same molar ratio as the
starting ethanol solution concentration (Section S7.1.4).
Both FFA solid solutions proved more challenging to
produce due to the increased dissimilarity between molecular
components. The MFA/FFA solid solution was prepared by
crystallization from the melt after failed attempts to obtain the
solid solution by crystallization from ethanol solution (Section
7.1.5−6). It is isomorphous with MFA I, but contains only a
maximum of ∼70% FFA. The TFA/FFA solid solution can be
formed from ethanol solution up to 50% FFA molar ratio
(Section S7.1.8).
3.4. Targeted Production of the First Crystals of TFA
VII. The TFA/FFA solid solution provided another new
fenamate crystal structure type, which can be readily prepared
and is suﬃciently stable to be used as template. Adding this to
the computational matrix (Table S9) suggested that the TFA
end point of the solid solution might be formed by subliming
TFA onto the solid solution TFA/FFA. This sublimation
experiment generated TFA VII which is isomorphous to the
solid solution of TFA/FFA, concomitantly with TFA II crystals
(Figure 4).
3.5. Control Experiments and Serendipitous Obser-
vation of Surface Polymorph TFA VIII. A variety of
additional control experiments, subliming MFA, TFA, and FFA
onto the template crystals MFA I, TFA I, FFA III, and the
TFA/FFA solid solution were attempted. These all resulted in
known polymorphs, frequently as mixtures (Section S7.2.1);
for example, FFA III and FFA I concomitantly formed on the
TFA/FFA solid solution template.
Sublimation of TFA onto a variety of metal and glass
surfaces generally gave TFA I, though controlled sublimation50
onto copper gives a new form TFA VIII. The structure was
determined by PXRD. The powder samples were mixtures of
TFA I (P21/c, Z′ = 1) and a new form TFA VIII (P1̅, Z′ = 1)
which has the same layers stacked in a diﬀerent way (Figure 5).
The proportion of TFA VIII was greater when less material
was sublimed at lower temperatures. Some evidence of
polymorph TFA VIII has also been found in samples obtained
by sublimation51 onto smooth Ag or Cu surfaces (Section S8).
4. DISCUSSION
4.1. Do Similar Molecules Have Isostructural Struc-
tures That Are Thermodynamically Plausible, As
Generated by CSP Methods? At the start of this study,
the many known polymorphs of the heavily screened
fenamates, MFA, TFA, and FFA all had distinct structures,
despite MFA and TFA molecules being related by a Cl/CH3
interchange, which often results in isomorphous crystals, and
FFA having one smaller and one similar substituent. The steric
similarity accounts for the crystal energy landscapes (Figure 2,
Table S9) having matches between most of the observed Z′ =
1 polymorphs and computer generated structures for the other
molecules, within the large 15 kJ/mol window. There are many
additional computer-generated structures, particularly for FFA.
In comparing the relative energies of the matched structures
(Table S9), it becomes clear that MFA and TFA have common
structures that are similar in relative stability, but FFA
structures have a very diﬀerent energy ranking; i.e., when
only the low energy structures, within the range of observed
polymorphs, are examined, there are some matches between
MFA and TFA, but most matches with FFA are high in energy
and vice versa. (An exception is that substituting TFA in FFA
II is only slightly less stable than any known TFA polymorph.)
On adding the experimental constraint that the templating
crystal needs to be stable during the experiment, the most
promising unobserved thermodynamically plausible polymorph
was experimentally realized as TFA VI. The addition of the
TFA/FFA solid solution structure to the matrix suggested that
Figure 4. (Left) The new polymorph TFA VII (circled red) formed
concomitantly with TFA II (blue), by sublimation onto the
isomorphous P21/c TFA/FFA solid solution template crystals.
(Right) The hydrogen bonded layer, denoted in silver and gold, is
identical with that of the P1̅ structure TFA VI (which is isomorphous
with MFA I, MFA/TFA, and MFA/FFA) with an RMSD12 = 0.19 Å
but diﬀers in that the layers are not stacked but related by the glide/
screw (purple and green) giving a T interaction of type 6aβ (as
deﬁned in Figure S2).
Figure 5. New polymorph TFA VIII has the same layers of dimers as
the most stable form at room temperature, TFA I, but stacked by
lattice translation rather than a P21/c screw axis. The interface
between these layers is marked by a dashed red line, and the b axes of
the two structures (green), which diﬀer in length by roughly a factor
of 2, are aligned.
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the structure which was found as TFA VII was intermediate in
stability between the ordered and disordered metastable
polymorphs of TFA, and that if MFA could adopt the
structure it would be only slightly less stable than any of its
known polymorphs. By the completion of this study, we had
generated a polymorph of TFA isomorphous with MFA I,
namely, TFA VI, and two new fenamate structure types, TFA
VIII and the TFA/FFA solid solution with its isomorphous
single component end point, TFA VII.
The key to successful templating is the thermodynamic
plausibility of a new polymorph, which depends on the
possible thermodynamic metastability of experimental poly-
morphs, and the likely errors in the relative stability as
estimated by lattice energy calculations used in the CSP
studies. We assessed the computational error by calculating the
relative energies of all the experimental structures and the
corresponding structures generated by substituting the
alternative molecules into these lattices, by a range of
dispersion-corrected periodic density functional theory meth-
ods, and also by the approximate inclusion of free energy or the
eﬀect of polarization as variations on the method used for the
CSP study. The results (Section S4) vary as would be
expected52,53 from the known limitations of all current
computational methods for relative polymorph stability and
are in reasonable agreement with the limited experimentally
established Gibbs free energy diﬀerences between polymorphs
and evidence for low temperature stability order21,22 (Section
S4.1). Most calculations, including the most expensive periodic
DFT-D calculations with the most theoretically justiﬁed
dispersion correction (PBE-MBD*) (Figure 6) show that the
observed polymorphs are more stable than the unobserved
isostructural equivalents and conﬁrm that the templating
experiments were targeting metastable structures. We have
found new polymorphs of TFA, which are comparable in
stability with those found by polymer induced heteronuclea-
tion, but not the MFA equivalents of TFA polymorphs which
would be less stable than the known MFA polymorphs. The
FFA equivalents would be highly metastable.
The closeness of the polymorphs’ energies reﬂects the
compromise between conformational distortions, the van der
Waals dispersion, and π···π stacking interactions between the
aromatic groups, and minor distortions of the common
hydrogen bonding motif, with TFA and FFA adding halogen
interactions into the mix of contributions which are being
balanced. Analyzing the energy diﬀerences (Figure 6) helps
explain why the most stable polymorphs diﬀer and why there
are not more isostructural structures adopted by these
chemically similar molecules. The packing of FFA III is
markedly more stable for FFA than it would be for TFA or
MFA, as it adopts a conformation in which there is a steric
clash between the additional methyl groups of MFA and TFA
(Figure 7). All three molecules have a double well in the
conformational energy, which can be attributed to the
compromise between conjugation of the two aromatic rings
favoring planar structures and the steric clash of the
substituents54 and gives a similar small barrier when ϕ = 0°
corresponding to only proximity of hydrogen atoms. However,
for FFA, the barrier for perpendicular rings is high and
conformations with ϕ ≈ 180° accessible, whereas TFA and
MFA have a lower energy barrier for perpendicular rings and a
very high barrier around a planar conformation due to close
approach of the methyl substituents. Thus, MFA and TFA
cannot adopt the structures of FFA III, IV, VI, and VII because
these contain at least one molecule in a high energy
conformation (Figure S3). TFA and MFA have crystalline
conformations in both wells, and there is only a small energy
barrier between all observed conformations in isolation. The
diﬀerences in low energy conformations may explain why MFA
can be incorporated as an impurity into FFA I55,56 more readily
than FFA III and that the MFA impurity inhibits the
polymorphic transition from FFA I to III. In the case of FFA
growth on other templates, the large barrier for FFA III
Figure 6. Relative lattice energies of the observed (□) Z′ = 1
nondisordered polymorphs and computational substitutions of the
other molecules in the same structures (×); the geometry is optimized
at the PBE-TS level, and single point energies are evaluated by PBE-
MBD*. The energies are relative to the experimentally most stable
low temperature polymorphs, i.e., FFA III, MFA I, and TFA II. The
color code for the molecules in the crystal structures is followed on
the axes, with the solid solutions in blue and the structures used as
templates in sublimation experiments in large bold type. See Section
S4 for a detailed analysis of relative energies by a variety of
computational models and comparison with experimental stabilities.
Figure 7. Intramolecular (conformational) energy (ΔEintra) at the
PBE0/6-31+G(d) level of theory for the three molecules as a function
of ϕ. The range of dihedral angles observed in solid solutions and
polymorphs which are isostructural with MFA I and TFA VII are
shown, as is the dihedral angle found in FFA III. All experimental
angles are listed in Table S1 and shown in the individual
conformational proﬁles, Figure S3.
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molecules to change conformation to the shape adopted by
MFA and TFA polymorphs may also provide a kinetic barrier
to forming new FFA polymorphs.
The other component of the lattice energies is the
intermolecular energy. The carboxylic acid R2
2(8) hydrogen
bond is the same in all structures, and so the main causes of the
energy diﬀerences come from the packing of the substituted
aromatic rings. The classiﬁcation in Figure S2 of these
interactions shows that the MFA I structure has methyl to
methyl interactions, which can have one CH3 replaced by Cl
for TFA, or plausibly be adopted by FFA. This accounts for
MFA I being the most commonly observed structural type,
with the MFA/TFA solid solution existing continuously
between the MFA I and TFA VI end points, and the MFA/
FFA solid solution accommodating up to 70% FFA in this
structure. All MFA polymorphs have the pair of methyl groups
adjacent. MFA and TFA are similar in that the nonacidic rings
are often approximately coplanar, but TFA has a wider range of
contacts, with those where the Cl is near an aromatic hydrogen
being the more stable. FFA appears to have a preference for
structures in which CF3 groups are aligned. There are some
crystal structures of TFA and FFA where the substituents are
pointing into the aromatic ring, including TFA VIII. This is the
main packing diﬀerence between the MFA solid solution
structures (MFA I) and the TFA/FFA solid solution (Figure
4). Overall, although the molecular diﬀerences can be used to
rationalize the diﬀerences in the low energy crystal structures,
the diﬀerent contributions have to be balanced using high-level
calculations.
4.2. Use of Templates To Generate the First Crystals
of a Predicted Isostructural Polymorph. The production
of TFA VI by sublimation onto the isomorphous template of
MFA I is a clear success of the principle of using CSP to
establish that there is an unobserved low energy polymorph
that is isostructural with an available template that can be used
in the sublimation experiment. The two molecules also form a
solid solution with the same structure, with the molecules in
the input ratio. This success in getting TFA to adopt the most
stable structure for MFA seemed likely from the Cl/CH3
exchange principle and is fully consistent with the calculated
lattice energies. The robustness of the novel TFA VI is shown
by its being formed in distinct sublimation experiments and by
seeding ethanolic solutions.
The second new polymorph produced by sublimation onto a
template is the formation of TFA VII on the TFA/FFA solid
solution. This structure diﬀers from the MFA I type, purely in
the packing of the layers, reﬂecting the diﬀerences in the
substituents. Thus, TFA can adopt either layer packing, but
neither MFA nor FFA can, which is consistent with TFA being
in both solid solution structures, but FFA being only partially
absorbed into both solid solutions, and MFA I being the only
solid solution structure for MFA.
4.3. Thermodynamic and Kinetic Feasibility of the
Polymorphs. All the new polymorphs of TFA are metastable,
and hence their formation is in kinetic competition with the
more stable structures, and the time taken for characterization
requires a slow transformation rate (TFA VI crystals were
stable for more than a week and TFA VII for more than a day).
There is no clear dividing line in the allowed degree of
thermodynamic metastability (Figure 6); for example, a highly
metastable form of MFA could have been templated by TFA I
or the TFA/FFA solid solution, both of which only gave MFA
I. The comparison of the observed polymorphs (Figure 8)
shows a high degree of similarity between MFA I, the most
Figure 8. Similarities between the polymorphs of the fenamates shown as n, the number of molecules in the best cluster overlay between the two
structures (n ≤ 15). Forms labeled in blue are the most stable at low temperatures, those in red at high temperature, and novel structures reported
in this work in green. The comparisons of all the polymorphs of a molecule with others of the same molecule are shown as matrices, labeled with
space group (Z′). The comparisons of polymorphs of one molecule with those of another are all shown on the cubic graph. Numerical values of
RMSDn are included in Tables S2−S7. FFA VIII with Z′ = 8.5 is not included.
Crystal Growth & Design Article
DOI: 10.1021/acs.cgd.8b00765
Cryst. Growth Des. 2018, 18, 5322−5331
5327
stable form, and the metastable TFA polymorphs, so MFA is
unlikely to be long-lived in an isostructural equivalent to TFA
III, IV, or VII. The challenges in obtaining the known
metastable forms of MFA as single crystals have been
attributed to the ease of conversion to the stable form.25 A
study of the epitaxial growth of MFA onto FFA I and FFA III56
found that the substrate aﬀected the rate and orientation of
crystalline growth, but it was MFA I that was formed.
4.4. Implications for the Design/Choice of Templates.
The successful selection of templating crystals by modeling
raises the question: when a CSP study shows that a molecule
has unobserved yet potentially important thermodynamically
plausible polymorphs, how you ﬁnd a suitable template?
Searching the CSD for an isostructural match to the CSP
generated low energy structure, ignoring small molecular
diﬀerences, might suggest a suitable template crystal for the
targeted structure. The ability of the two molecules to form
solid solutions also appears to be a useful indicator that the
isostructurality is close enough. However, when the solid
solution range is not continuous across all relative concen-
trations, as observed for FFA, sublimation has not produced
the isomorphous FFA end-point. Practically, the sensitivity of
the relative lattice energies to molecular changes, even as subtle
as changing CH3 for Cl, shown by the CSP studies (Figure 2),
implies that it is likely to be rare that these conditions of close
isostructurality are met. The kinetic eﬀects that are operational
in templating the formation of new polymorphs occur at the
surface, and so we might hope that a suitable template crystal
need only have some surfaces that could act as a template. We
have explored the compatibility between diﬀerent crystal
surfaces by docking nanocrystals57 (of 25 molecules cut from
the optimized target crystal structure) onto the idealized
dominant crystal surfaces of the templates. (Section S5). These
calculations show (Figure 9) that TFA can interact very
strongly with the MFA I template surface supporting the
formation of TFA VI by templating. In contrast FFA cannot
form a stable structure that is closely isostructural to MFA I
(RMSD14 = 0.7 Å Table S9), and so the registry between the
nanocrystal of FFA in this structure with the MFA I surface is
poor. The results for the templating onto the TFA/FFA solid
solution are less clear-cut, but the TFA VII structure that is
templated by this crystal does have the strongest interaction
(Figure 9 Table S12). The nanocrystal results are consistent
with the bulk crystal energy predictions for templating and the
experimental results, and so this approach may be useful for
exploring surface matches that do not involve isostructural
crystals. The idea of using nanocrystal to surface interactions
has been used to establish the compatibility of two surfaces in
various contexts, including determining possible agglomerating
faces,57 accounting for surface templating favoring a particular
hydration product58 or cocrystal growth,59 and establishing
epitaxy60,61 as a quantiﬁcation of two crystals sharing the same
surface structure.62 A smaller cluster can explain why seeding
solutions with MFA I and FFA I produces TFA VI (Section
S6). The similar surface is expected to lower the nucleation
barrier to forming the new, possibly metastable form,62 and the
nanocrystal represents establishing the new structure. These
simulations are far from realistic, as if the nanocrystal docking
onto unrelaxed surfaces represented the only templating
mechanism, this would result in only a lateral continuation
of the crystal growth. In our experiments, the fastest growing
crystals stick out from the crystal faces vertically (Figure 3
(left) and Figure 4 (left)), though lateral crystals were also
seen, as in the carbamazepine family templating experiments.16
Diﬀerent organic surfaces or functional groups have long
been associated with fenamate polymorphism, with many of
the TFA and FFA polymorphs being discovered by polymer
induced heteronucleation.21 FFA can be used as an additive to
produce the metastable MFA II,63 and MFA III was found
serendipitously in a failed cocrystallization with adenine.26 FFA
V can be produced by addition of a salt additive,63 and we have
also observed FFA V being formed when attempting to prepare
a TFA/FFA solid solution with a high proportion of FFA
(Table S16). The geometry of cellulose nanopores aﬀects
whether MFA I or II is crystallized.28 Self-assembled
monolayers have templated mixtures of known forms of TFA
and FFA, including TFA “Form X”, which seems to be a
mixture of TFA I and II.64 The observation of TFA VIII at the
early stages of deposition onto copper surfaces, which lack the
molecular structure of the isostructural templates, indicates
other substrates will have an eﬀect. However, our approach
leads to the design of templates to target the discovery of a
speciﬁc isostructural CSP predicted polymorph, and combines
both functional group and crystal geometry matching.
The fenamate molecules have an irregular shape, and the
CSP crystal energy landscapes show that all three molecules
have other thermodynamically feasible structures. Finding or
eliminating them from being possible polymorphs is
challenging to our understanding of what controls the
crystallization of ﬂexible drug molecules. The van der Waals
contacts of the ﬂexible fenamates contrast with the use of
isostructural templating to produce diﬀerent hydrogen bonding
motifs in the carbamazepine family of rigid molecules.16 This
shows that the methodology could have applicability across a
wide range of pharmaceutical molecules, given that many
closely related molecules are likely to have been crystallized in
drug discovery.
Figure 9. Dominant surfaces of the template crystals. Top: P1̅ MFA I
and bottom P21/c TFA VII representing the TFA/FFA solid solution,
showing the docking of 25 molecule nanocrystals of the same
structure composed of (left to right) TFA, MFA, and FFA. The
energy of docking the nanocrystal is color coded green for successful
templating experiments, black for previously known pure polymorphs,
and red for cases where templating did not produce a structure
corresponding to the nanocrystal. The dominant interactions in the
docking are the broadside substituent interactions (1a Figure S2) for
the P1̅ structure (top) and the T-shaped interaction (6aβ Figure S2)
for the P21/c structure (bottom).
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5. CONCLUSION
By studying the isostructurality of known and computer
generated crystal structures of three fenamate molecules, we
have produced two new polymorphs of TFA, with a third being
found by sublimation onto an inorganic surface. This is for a
molecule that has been heavily studied in developing
polymorph screening methods.23 The methodology originally
used in the carbamazepine family, of subliming molecules onto
isomorphous templates to produce the ﬁrst nucleation of a
predicted polymorph, has produced the ﬁrst isomorphous pair
of polymorphs (TFA VI and MFA I) within the fenamate
family. The generation of solid solutions has produced a new
fenamate structural type, the TFA/FFA solid solution, whose
single component end point could be obtained by sublimation
as TFA VII. There are more similarities in the current set of
polymorph structures between MFA and TFA than between
either and FFA (Figure 8). The diﬀerences in the conforma-
tional proﬁle of the molecules, and the variety of favored
packings of the substituents of the aromatic ring, account for
the diﬀerence in the relative stabilities of the diﬀerent packings
for the diﬀerent molecules. However, the subtle balance
between conformational energies and steric requirements to
provide dense packing with diﬀerent substituents is such that
controlling the crystallization of these fenamates is an
experimental and computational challenge. Since this arises
from the compromises between the shallow potential wells for
changing conformation and the weak intermolecular inter-
actions, this behavior is likely to be typical of polymorphism in
many pharmaceuticals.
This work shows that the targeted generation of new
polymorphs by isomorphous templating can be extended to
ﬂexible molecules, and weaker intermolecular interactions, but
is likely to require molecules with suﬃcient similarity to form
at least a partial isomorphous solid solution. This is a
signiﬁcant step forward in the ability to design speciﬁc
experiments to produce the ﬁrst crystals of pharmaceutical
polymorphs predicted by CSP.
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